JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, X.
Right arrow Articles by Cui, M.-Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, X.
Right arrow Articles by Cui, M.-Z.

J Biol Chem, Vol. 274, Issue 46, 32543-32546, November 12, 1999

COMMUNICATION
Identification of a Novel PSD-95/Dlg/ZO-1 (PDZ)-like Protein Interacting with the C Terminus of Presenilin-1*

Xuemin XuDagger §, Yong-chang ShiDagger , Xian Wu, Pierluigi Gambetti, Dexin Sui, and Mei-Zhen CuiDagger parallel

From the Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, the  Department of Biochemistry, Michigan State University, East Lansing, Michigan 48824, and the parallel  Department of Cell Biology, Cleveland Clinic Foundation, Cleveland, Ohio 44195

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Presenilin-1 (PS-1) is the most causative Alzheimer gene product, and its function is not well understood. In an attempt to elucidate the function of PS-1, we screened a human brain cDNA library for PS-1-interacting proteins using the yeast two-hybrid system and isolated a novel protein containing a PSD-95/Dlg/ZO-1 (PDZ)-like domain. This novel PS-1-associated protein (PSAP) shares a significant similarity with a Caenorhabditis elegans protein of unknown function. Northern blot analysis revealed that PSAP is predominantly expressed in the brain. Deletion of the first four C-terminal amino acid residues of PS-1, which contain the PDZ domain-binding motif (Gln-Phe-Tyr-Ile), reduced the binding activity of PS-1 toward PSAP 4-fold. These data suggest that PS-1 may associate with a PDZ-like domain-containing protein in vivo and thus may participate in receptor or channel clustering and intracellular signaling events in the brain.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

To date, familial forms of Alzheimer's disease have been linked to mutations in three different genes. The first is the amyloid precursor protein (APP)1 gene located on chromosome 21 (1). The other two genes are presenilin-1 (PS-1) and presenilin-2 (PS-2), located on chromosomes 14 and 1, respectively (2, 3). Mutations in all three genes lead to either increased total amounts of amyloid beta -peptide (Abeta ) or longer (42-43 amino acids) and hence more amyloidogenic Abeta formation. This supports the hypothesis that the aberrant processing of APP and the Abeta deposition are the primary pathogenic events in Alzheimer's disease development (for review see Ref. 4). However, the mechanism by which the mutant APP, PS-1, and PS-2 alter both APP processing and the normal function of these proteins remains obscure.

On the basis of the predicted multiple transmembrane structure, it has been suggested that presenilin proteins may function as signal receptors, form channels, or participate in protein trafficking (2). Evidence supporting a signaling function for PS-1 and PS-2 comes from studies showing that both wild-type PS-1 and PS-2 cDNAs can complement Sel-12, a Caenorhabditis elegans homologue of PS-1 (PS-2), which facilitates Notch/Lin-12 signaling and cell fate specification during development (5). The involvement of PS-1 in Notch-mediated signaling during mammalian embryogenesis has also been suggested by studies using knockout mice (6, 7). Furthermore, mutations in PS-1 and PS-2 have been implicated in apoptotic cell death (8, 9). Protein topological studies suggest that PS-1 and PS-2 proteins have six to eight transmembrane domains (2, 10-12). Despite the diversity, it is notable that in all the topological models, the C-terminal domain is oriented toward the cytoplasm. This suggests that the C-terminal domain might mediate protein-protein interactions. Furthermore, it has been shown that the C-terminal fragment of PS-2 functions as a dominant negative mutant in T-cell receptor-induced apoptosis (8). This role might be explained by competitive binding of the C-terminal fragment to an unknown factor, resulting in the inhibition of signal transduction mediated by PS-2.

We have used the C-terminal fragment of PS-1 as a probe to screen a human brain cDNA library for PS-1-interacting protein(s). In this report, we describe the molecular cloning and characterization of a novel molecule, PSAP (PS-1-associated protein), which interacts with the C terminus of PS-1. Sequence analysis revealed that PSAP contains several putative protein kinase C and tyrosine kinase phosphorylation sites and shares a significant similarity with a C. elegans protein of unknown function. Interestingly, it was also found that PSAP contains a PDZ domain-like structure, which may account for its binding to the C-terminal Phe-Tyr-Ile-COOH motif of PS-1, a consensus sequence of the PDZ domain-binding site.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Yeast Two-hybrid and cDNA Library Screening-- All yeast strains, plasmids, and the human brain cDNA library used in the two-hybrid experiments were from CLONTECH as components of the Matchmaker two-hybrid system. The C-terminal 79 amino acids of PS-1 (PS1C79) were fused to the GAL4 DNA binding domain by subcloning the polymerase chain reaction-amplified corresponding coding region into the pAS2-1 vector (pAS1C79). Yeast strain Y190 was co-transformed with the plasmid pAS1C79 and a human brain cDNA library fused to the GAL4 transcription activation domain in pACT2 vector. Two-hybrid screening was carried out according to the manufacturer's instructions (CLONTECH).

Galactosidase Assays-- The following plasmids were used in yeast mating experiments. Blank vectors pAS2-1 and pACT2, pVA3-1 (p53 gene in pAS2-1), pTD1-1 (SV40 large T antigen in pACT2), and pLAM5'-1 (the lamin C gene in pAS2-1) from CLONTECH were used as controls. Plasmid pACPSAP was isolated from one of the two positive clones. The pAS1C79 plasmid was constructed as described above. Plasmids pAS1Loop (amino acids 302-376 of PS-1), pAS1HP(7-8) (amino acids 263-407 of PS-1), deletion mutant pAS1C79(-4), which lacks the last C-terminal 4 amino acids of PS-1, and pAS2C79, which contains the last 79 amino acids of PS-2, were also constructed in the pAS2-1 vector. Plasmids based on the pAS2-1 vector were used to transform the yeast strain Y187. Plasmids based on the pACT2 vector were used to transform the yeast strain Y190. The mating experiments and color development assays were performed according to the manufacturer's instructions (CLONTECH). For qualitative evaluation of the interaction between PS1C79 and PSAP, galactosidase filter lift assays were performed. For quantitative studies, galactosidase activity was determined using the chemiluminescent Galacton-Star detection kit (CLONTECH).

Immunoprecipitation and Western Blot-- PS-1 with an N-terminal FLAG tag was subcloned into pCEP4. PSAP tagged with a Myc tag at the C terminus was subcloned into pCDNA3.1. HEK293 cells were stably transfected with a PSAP-expressing vector. To determine the interaction of PSAP with PS-1 in intact cells, cells stably expressing PSAP were further transiently transfected with PS-1 expression vector. The total cell lysate for immunoprecipitation was obtained as 18,000 × g supernatant after cell lysis in lysis buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5% Triton X-100, 5 mM EDTA) containing protease inhibitors on ice for 30 min. The supernatants were incubated with alpha -Myc (Invitrogen) or AD3L or anti-L (specific to the C-terminal fragment of PS-1 (10, 13)) and protein A-Sepharose overnight at 4 °C. The immunoprecipitates were separated by 10-16% Tris/glycine SDS-PAGE and probed with the appropriate antibody. The blots were visualized by ECL-Plus (Amersham Pharmacia Biotech).

Northern Blot Analysis-- Multiple tissue Northern blot (CLONTECH) containing 2 µg of poly(A)+ mRNA isolated from a variety of human tissues was probed with the 1.2-kb cDNA corresponding to the PSAP coding region. Northern hybridization was performed according to the manufacturer's instructions (CLONTECH). The blot was also probed with radiolabeled beta -actin cDNA (CLONTECH) as an indicator of RNA loading.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

PS-1 Interacts with a PDZ-like Domain-containing Protein-- Of 3.1 × 106 total clones screened using PS1C79 as a probe, two positive clones, 46 and 299, were isolated. To eliminate false positives, yeast-mating experiments were carried out. As shown in Table I, only the transformant pair that bears the bait plasmid pAS1C79 and the plasmid pACPSAP from clone 46, as well as the transformant pair that bears the positive control plasmids containing murine p53 and SV40 large T, were positive for the His3 phenotype and for beta -galactosidase activity, indicating a true positive interaction between PS1C79 and PSAP. Plasmid from clone 299 was also tested in the mating experiment, and the same results were observed (data not shown).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Interaction of PSAP with PS1C79 in the yeast two-hybrid system

Restriction mapping and DNA sequencing analysis indicated that these two clones are identical and contain a 1.9-kb cDNA. We have performed the 5'-RACE (rapid amplification of cDNA ends) reaction using human brain whole cDNA (CLONTECH), and no DNA fragment with a 5'-end longer than the insert in the two positive clones has been isolated. The putative open reading frame of 1113 base pairs encodes a polypeptide of 371 amino acids with a predicted mass of 39.9 kDa, designated as PSAP (Fig. 1A). Sequence analysis of PSAP using "Prosite" revealed six consensus sites for phosphorylation by protein kinase C, three by casein kinase II, one by cAMP-dependent kinase, and one by tyrosine kinase (Fig. 1A). A BLAST search of GenBankTM revealed that PSAP is novel but shares homology (28% identity, 65% similarity) with a C. elegans protein, F43E2.7, of unknown function (14). It was also found that PSAP contains a GLLGF sequence preceded by a basic amino acid lysine that is similar to the conserved motif, R(K)XXXXXGLGF, found in most PDZ proteins and as seen in the binding pocket of a typical PDZ protein, PSD-95 (15). The overall homology between the PDZ-like domain (amino acids 222-304) of PSAP and typical PDZ domains is lower but significant, 12-14% identical in 80-95 amino acids (Fig. 1B). PSAP, like the Vesl/Homer family protein (16, 17), may represent another unique member of the PDZ protein super-family.


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 1.   Sequence analysis of PSAP. A, amino acid sequence of PSAP. Putative sites of phosphorylation by protein kinase C are circled, those by casein kinase are boxed, that by tyrosine kinase is shown in bold underlined letters, and that by cAMP-dependent kinase activity is shown in bold letters. B, amino acid sequence alignment between the PDZ-like domains of PSAP and other PDZ domain proteins. Residues identical to or similar to the PSAP sequence are heavily shaded or lightly shaded, respectively.

PS1C79 Interacts with PSAP in a Specific Manner-- To determine the specificity of the interaction of PS1C79 with PSAP, we tested whether other fragments of PS-1, including the large loop between the sixth and seventh transmembrane domains, interact with PSAP in the yeast two-hybrid system. As shown in Table I, none of the tested fragments interacts with PSAP. The finding that the fragment HP(7-8), which contains two hydrophobic regions flanking the large hydrophilic loop, failed to interact with PSAP indicates that the interaction between PS1C79 and PSAP is specific and not due to the hydrophobic binding. The direct and specific interaction between PS1C79 and PSAP was also confirmed by an in vitro binding assay using a glutathione S-transferase-PS fusion protein and a 35S-labeled PSAP protein.2 We also tested whether the C-terminal 79-residue region of PS-2, which is highly conserved between PS-1 and PS-2, interacts with PSAP. As shown in Table I, PS2C79 failed to interact with PSAP in the yeast two-hybrid assay.

PSAP Interacts with Full-length PS-1 in Intact Cells-- HEK293 cells stably expressing Myc-tagged PSAP were transiently transfected with plasmid encoding FLAG-tagged PS1. As a control, cells stably expressing Myc-tagged LacZ were also transiently transfected with PS-1. Twenty-eight hours later, cells were lysed and then co-immunoprecipitated, and Western blot analysis was performed. As shown in Fig. 2, PS-1 was specifically co-immunoprecipitated with PSAP by anti-Myc antibody. This result indicates that PSAP interacts with PS-1 in intact cells.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 2.   Interaction of PSAP and PS-1 in transfected cells. Antibodies used for immunoprecipitation and for detection are indicated on the top and the bottom of the figure. Samples in lanes 1-4 were boiled in reducing buffer. Samples in lanes 5-12 were prepared in nonreducing buffer and unboiled. FLAG-tagged PS-1 (PS1) was specifically co-immunoprecipitated with PSAP from cells co-transfected with both PSAP and PS-1 cDNA (lane 6). The bands labeled H and L in lanes 1-4 correspond to the heavy chain and light chain, respectively, of the mouse anti-Myc antibody used for immunoprecipitation. These bands were detected as large complexes in lanes 5-8 under nonreducing conditions. Because the antibody AD3L, used for immunoprecipitation in lanes 9-12, was raised from rabbit, no corresponding bands were detected by an anti-mouse secondary antibody.

PS1C79-PSAP Interaction Requires the C-terminal Gln-Phe-Tyr-Ile-COOH Motif of PS-1-- Ligand interaction studies have revealed that PDZ domains bind to a consensus sequence in the C terminus of the target protein, which contains a hydrophobic or an aromatic amino acid as the last amino acid (18). On the basis of the primary sequences, two large groups of unique C-terminal motifs of target proteins are recognized by two PDZ domain classes. Class I PDZ domain binds to a C-terminal motif with the sequence Ser/Thr-X-Val/Ile-COOH. In contrast, class II PDZ domains have a preference for Phe/Tyr-X-Phe/Val/Ale/?-COOH (18). We examined PS-1 for this motif and found a sequence, Gln-Phe-Tyr-Ile-COOH, at the extreme C terminus of PS-1. The glutamine residue at the -4 position was also shown to influence the interaction (18). To determine whether the sequence Gln-Phe-Tyr-Ile-COOH is the PSAP-binding motif of PS-1, we deleted this sequence in PS1C79. This mutant, PS1C79(-4), interacts poorly with PSAP and the binding activity was reduced by 4-fold compared with native PS1C79 (Fig. 3 and Table I). This result indicates that the sequence Gln-Phe-Tyr-Ile-COOH in PS-1 is required for optimal interaction with PSAP.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 3.   Quantitative galactosidase assay. The mating experiments were performed using the same plasmids as described in Table I. Galactosidase activity was determined using the chemiluminescent Galaton-Star detection kit. The values presented are the average of three independent transformant assays.

PSAP Is Expressed Predominantly in the Brain-- Expression of PSAP mRNA in human tissues was examined by Northern blot analysis. The PSAP cDNA was used to probe Northern blots containing poly(A)+ RNA from human tissues. A 1.9-kb mRNA was detected in all tissues examined. The highest levels are observed in the brain, with lower levels in the heart and barely detectable levels in other tissues (Fig. 4). The size of the PSAP mRNA detected in Northern blots is consistent with the size of the PSAP cDNA isolated using the two-hybrid system.


View larger version (67K):
[in this window]
[in a new window]
 
Fig. 4.   Northern blot analysis of PSAP RNA. RNA from various human tissues: Heart, Brain, Placenta, Lung, Liver, skeletal (Sk.) muscle, Kidney, and Pancreas, as indicated. Upper panel, the blots were hybridized with a probe generated from PSAP cDNA. Lower panel, the blot was probed with radiolabeled beta -actin cDNA as an indicator of RNA loading.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In the present study, we identified a novel protein, PSAP, that interacts with the C terminus of PS-1 and contains a PDZ-like domain, a motif thought to mediate protein-protein interactions and to be involved in cellular junction formation, receptor or channel clustering, and cellular signaling events. PS-1 has been implicated in the Notch/Sel-12 signaling pathway; thus, the direct interaction of PSAP with the C terminus of PS-1 may play a regulatory role in PS-1-mediated Notch and/or wingless signal transduction by analogizing the function of Dsh, which contains one PDZ domain and is required for signal transduction from seven-transmembrane receptors, frizzled and Dfz2, in the wingless signal pathway in Drosophila. (for review see Ref. 19).

One of the important functions of PDZ domain-containing proteins is in the clustering and localization of specific classes of ion channels at synapses and possibly other sites of membrane specialization in neurons. Recently, it has been reported that the overexpression of PS-1 and PS-2 up-regulates functional K+ channel expression either by directly associating with K+ channel pore-forming subunits or by indirectly increasing the synthesis, assembly, and/or transport of these subunits to the plasma membrane (20). The mechanism underlying the effects of presenilins on ion channels is not understood. Studies employing cell culture systems or transgenic mice have shown that Alzheimer mutant presenilins influence APP processing in a manner that elevates production of the longer and more amyloidogenic Abeta (4). However, whether this aberrant Abeta production results from the alteration of protein trafficking caused by mutant presenilin remains to be established. By analogizing the function of the known PDZ proteins, further investigation on the role of the direct interaction between PSAP and PS-1 will provide important information on these issues.

In a recent study, we found that PS-1 has a regulatory effect on the GTPase activity of Go and may function as a G protein-coupled receptor (21). It is notable that about 30% of known G protein-coupled receptors contain the PDZ-binding sequence (22). In Drosophila, a PDZ domain-containing protein, InaD, serves as a scaffold to assemble different signaling molecules of the Gq-regulated phototransduction cascade (23). By analogy, this implies a potential role for PSAP in the Go-regulated signaling pathway mediated by PS-1.

PSAP contains only one PDZ-like domain and no other modular domains such as Src homology 2 (SH2), SH3, or pleckstrin homology (PH). However, PSAP contains several potential protein kinase phosphorylation sites by various kinases. These phosphorylation sites may be important for the regulation of the function of PSAP by the kinase activities and/or important in mediating the interaction of PSAP with other molecules.

It is also noteworthy that PSAP specifically interacts with PS-1 but not PS-2. This may be because of the substitution of Leu for Phe at position -3 in PS-2. This result suggests that PS-1 and PS-2 may be involved in different signaling pathways. The differences in the physiological regulation and/or function of PS-1 and PS-2 were also suggested by the observations that PS-1 and PS-2 possess different phosphorylation patterns (24, 25).

In conclusion, we have identified a novel molecule, PSAP, a unique PDZ domain-containing protein that specifically binds to PS-1. Mutational analysis revealed that the C-terminal Gln-Phe-Tyr-Ile-COOH, motif of PS-1 is required for the interaction with PSAP. PSAP is predominantly expressed in the brain and may function as an adaptor molecule that links PS-1 to an intracellular signal transduction pathway. This finding may open a new avenue for determining the normal and pathological functions of PS-1 and the mechanism by which PS-1 is involved in Alzheimer's disease.

    ACKNOWLEDGEMENTS

We thank Dr. Peter H. St. George-Hyslop (University of Toronto, Toronto, Canada) for providing the PS-1 and PS-2 cDNAs; Dr. Hiroshi Mori (Tokyo Institute of Psychiatry, Tokyo, Japan) and Dr. Gopal Thinakaran (The Johns Hopkins University, Baltimore, MD) for providing antibodies specific to the C terminus of PS-1; and Dr. Paul Copeland and Allison Winokur for critical reading of this manuscript.

    FOOTNOTES

* This work was supported by Alzheimer's Association Grant PRG-98-006 and a pilot grant from Sigma Kappa (to X. X.), National Institutes of Health Grants NS-37869-01 (to X. X.), P50 AG08012 (to the Alzheimer Center at Case Western Reserve University), and AG08992 (to P. G.), and the Britton fund.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF189289.

Dagger Current address: Dept. of Pathology, University of Tennessee, 2407 River Dr., Knoxville, TN 37996.

§ To whom correspondence should be addressed (see "Current address"). Tel.: 423-974-8206; Fax: 423-974-5616; E-mail: xmx@utk.edu.

2 X. Xu, Y.-c. Shi, X. Wu, P. Gambetti, D. Sui, and M.-Z. Cui, manuscript in preparation.

    ABBREVIATIONS

The abbreviations used are: APP, amyloid precursor protein; Abeta , amyloid beta -peptide; PS, presenilin; PSAP, PS-1-associated protein; PDZ, PSD-95/Dlg/ZO-1; kb, kilobase pair.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., Multhaup, G., Beyreuther, K., and Muller-Hill, B. (1987) Nature 325, 733-736[CrossRef][Medline] [Order article via Infotrieve]
2. Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A. C., and Montesi, M. P. (1995) Nature 375, 754-760[CrossRef][Medline] [Order article via Infotrieve]
3. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C. E., Jondro, P. D., Schmidt, S. D., Wang, K., Crowley, A. C., Fu, Y.-H., Guanetta, S. Y., Galas, D., and Nemens, E. (1995) Science 269, 973-977[Abstract/Free Full Text]
4. Selkoe, D. J. (1997) Science 275, 630-631[Free Full Text]
5. Levitan, D., and Greenwald, I. (1995) Nature 377, 351-354[CrossRef][Medline] [Order article via Infotrieve]
6. Wong, P. C., Zheng, H., Chen, H., Becher, M. W., Sirinathsinghji, D. J., Trumbauer, M. E., Chen, H. Y., Price, D. L., Van der Ploeg, L. H., and Sisodia, S. S. (1997) Nature 387, 288-292[CrossRef][Medline] [Order article via Infotrieve]
7. Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D. J., and Tonegawa, S. (1997) Cell 89, 629-639[CrossRef][Medline] [Order article via Infotrieve]
8. Vito, P., Ghayur, T., and D'Adamio, L. (1997) J. Biol. Chem. 272, 28315-28320[Abstract/Free Full Text]
9. Guo, Q., Sopher, B. L., Furukawa, K., Pham, D. G., Robinson, N., Martin, G. M., and Mattson, M. P. (1997) J. Neurosci. 17, 4212-4222[Abstract/Free Full Text]
10. Doan, A., Thinakaran, G., Borchelt, D. R., Slunt, H. H., Ratovitsky, T., Podlisny, M., Selkoe, D. J., Seeger, M., Gandy, S. E., Price, D. L., and Sisodia, S. S. (1996) Neuron 17, 1023-1030[CrossRef][Medline] [Order article via Infotrieve]
11. Lehmann, S., Chiesa, R., and Harris, D. A. (1997) J. Biol. Chem. 272, 12047-12051[Abstract/Free Full Text]
12. Dewji, N. N., and Singer, S. J. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 14025-14030[Abstract/Free Full Text]
13. Yamamoto, A., Sahara, N., Usami, M., Okochi, M., Kondo, T., Kametani, F., Tanaka, K., Yahagi, Y., Shirasawa, T., Itoyama, Y., and Mori, H. (1996) Biochem. Biophys. Res. Commun. 226, 536-541[CrossRef][Medline] [Order article via Infotrieve]
14. Wilson, R., Ainscough, R., Anderson, K., Baynes, C., Berks, M., Bonfield, J., Burton, J., Connell, M., Copsey, T., Cooper, J., Coulson, A., Craxton, M., Dear, S., Du, Z., and Durbin, R. (1994) Nature 368, 32-38[CrossRef][Medline] [Order article via Infotrieve]
15. Doyle, D. A., Lee, A., Lewis, J., Kim, E., Sheng, M., and MacKinnon, R. (1996) Cell 85, 1067-1076[CrossRef][Medline] [Order article via Infotrieve]
16. Brakeman, P. R., Lanahan, A. A., O'Brien, R., Roche, K., Barnes, C. A., Huganir, R. L., and Worley, P. F. (1997) Nature 386, 284-288[CrossRef][Medline] [Order article via Infotrieve]
17. Kato, A., Ozawa, F., Saitoh, Y., Fukazawa, Y., Sugiyama, H., and Inokuchi, K. (1998) J. Biol. Chem. 273, 23969-23975[Abstract/Free Full Text]
18. Songyang, Z., Fanning, A. S., Fu, C., Xu, J., Marfatia, S. M., Chishti, A. H., Crompton, A., Chan, A. C., Anderson, J. M., and Cantley, L. C. (1997) Science 275, 73-77[Abstract/Free Full Text]
19. Ponting, C. P., Phillips, C., Davies, K. E., and Blake, D. J. (1997) Bioessays 19, 469-479[CrossRef][Medline] [Order article via Infotrieve]
20. Malin, S. A., Guo, W.-X. A., Jafari, G., Goate, A. M., and Nerbonne, J. M. (1998) Neurobiol. Dis. 4, 398-409[CrossRef][Medline] [Order article via Infotrieve]
21. Smine, A., Xu, X., Nishiyama, K., Katada, T., Gambetti, P., Yadav, S. P., Wu, X., Shi, Y. C., Yasuhara, S., Homburger, V., and Okamoto, T. (1998) J. Biol. Chem. 273, 16281-16288[Abstract/Free Full Text]
22. Ranganathan, R., and Ross, E. M. (1997) Curr. Biol. 7, R770-R773[CrossRef][Medline] [Order article via Infotrieve]
23. Tsunoda, S., Sierralta, J., Sun, Y., Bodner, R., Suzuki, E., Becker, A., Socolich, M., and Zuker, C. S. (1997) Nature 388, 243-249[CrossRef][Medline] [Order article via Infotrieve]
24. Walter, J., Capell, A., Grunberg, J., Pesold, B., Schindzielorz, A., Prior, R., Podlisny, M. B., Fraser, P., Hyslop, P. S., Selkoe, D. J., and Haass, C. (1996) Mol. Med. 2, 673-691[Medline] [Order article via Infotrieve]
25. Seeger, M., Nordstedt, C., Petanceska, S., Kovacs, D. M., Gouras, G. K., Hahne, S., Fraser, P., Levesque, L., Czernik, A. J., George-Hyslop, P. S., Sisodia, S. S., Thinakaran, G., Tanzi, R. E., Greengard, P., and Gandy, S. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 5090-5094[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
V. Lamarca, A. Sanz-Clemente, R. Perez-Pe, M. J. Martinez-Lorenzo, N. Halaihel, P. Muniesa, and J. A. Carrodeguas
Two isoforms of PSAP/MTCH1 share two proapoptotic domains and multiple internal signals for import into the mitochondrial outer membrane
Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1347 - C1361.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Spasic, A. Tolia, K. Dillen, V. Baert, B. De Strooper, S. Vrijens, and W. Annaert
Presenilin-1 Maintains a Nine-Transmembrane Topology throughout the Secretory Pathway
J. Biol. Chem., September 8, 2006; 281(36): 26569 - 26577.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Leibowitz-Amit, G. Tsarfaty, Y. Abargil, G. M. Yerushalmi, J. Horev, and I. Tsarfaty
Mimp, a Mitochondrial Carrier Homologue, Inhibits Met-HGF/SF-Induced Scattering and Tumorigenicity by Altering Met-HGF/SF Signaling Pathways.
Cancer Res., September 1, 2006; 66(17): 8687 - 8697.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Laudon, E. M. Hansson, K. Melen, A. Bergman, M. R. Farmery, B. Winblad, U. Lendahl, G. von Heijne, and J. Naslund
A Nine-transmembrane Domain Topology for Presenilin 1
J. Biol. Chem., October 21, 2005; 280(42): 35352 - 35360.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Gupta, R. Singh, P. Datta, Z. Zhang, C. Orr, Z. Lu, G. DuBois, A. S. Zervos, M. H. Meisler, S. M. Srinivasula, et al.
The C-terminal Tail of Presenilin Regulates Omi/HtrA2 Protease Activity
J. Biol. Chem., October 29, 2004; 279(44): 45844 - 45854.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Lamy, M. Ticchioni, A. K. Rouquette-Jazdanian, M. Samson, M. Deckert, A. H. Greenberg, and A. Bernard
CD47 and the 19 kDa Interacting Protein-3 (BNIP3) in T Cell Apoptosis
J. Biol. Chem., June 20, 2003; 278(26): 23915 - 23921.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-Y. Ni, H. Yuan, and G. Carpenter
Role of the ErbB-4 Carboxyl Terminus in gamma -Secretase Cleavage
J. Biol. Chem., February 7, 2003; 278(7): 4561 - 4565.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Xu, Y.-c. Shi, W. Gao, G. Mao, G. Zhao, S. Agrawal, G. M. Chisolm, D. Sui, and M.-Z. Cui
The Novel Presenilin-1-associated Protein Is a Proapoptotic Mitochondrial Protein
J. Biol. Chem., December 6, 2002; 277(50): 48913 - 48922.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. J. Selkoe
Alzheimer's Disease: Genes, Proteins, and Therapy
Physiol Rev, April 1, 2001; 81(2): 741 - 766.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Tanahashi and T. Tabira
Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein
Hum. Mol. Genet., September 1, 2000; 9(15): 2281 - 2289.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, X.
Right arrow Articles by Cui, M.-Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, X.
Right arrow Articles by Cui, M.-Z.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.